Business
Immutep (ASX:IMM) share price hikes amid clinical trial momentum in FY21
Image source: Getty Images
Shares in clinical stage biotechnology company Immutep Ltd (ASX: IMM) are inching higher in afternoon trading, up 2.5% to 62 cents apiece.
Immutep’s share price has been on the move amid the release of its annual report today, in which several investment…
Continue Reading
-
Noosa News16 hours agoElderly pair killed in rural highway intersection crash with caravan
-
Business17 hours ago3 of the best ASX shares to buy with $5,000
-
General23 hours agoAlbanese’s anaemic neutrality risks Aukus
-
General22 hours agoFormer Russian President Dmitry Medvedev issues warning over Ukraine escalation